Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2806)
All Articles published online
|
Sep 28, 2007 (publication date) through Dec 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zeisel MB, Fafi-Kremer S, Fofana I, Barth H, Stoll-Keller F, Doffoël M, Baumert TF. Neutralizing antibodies in hepatitis C virus infection. World J Gastroenterol 2007; 13(36): 4824-4830 [PMID: 17828813 DOI: 10.3748/wjg.v13.i36.4824] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i36/4824.htm |
| Number | Citing Articles |
| 1 |
Stanley M. Lemon, Patrizia Farci, Marc G. Ghany. The Liver. 2009; : 877 doi: 10.1002/9780470747919.ch53
|
| 2 |
Mahmoud Aboelneen Khattab. Targeting host factors: A novel rationale for the management of hepatitis C virus. World Journal of Gastroenterology 2009; 15(28): 3472-3479 doi: 10.3748/wjg.15.3472
|
| 3 |
Frédéric Schramm, Eric Soulier, Cathy Royer, Thierry Weitten, Samira Fafi‐Kremer, Nicolas Brignon, Nicolas Meyer, Bernard Ellero, Marie‐Lorraine Woehl‐Jaegle, Carole Meyer, Philippe Wolf, Michel Doffoël, Thomas F. Baumert, Françoise Stoll‐Keller, Evelyne Schvoerer. Frequent Compartmentalization of Hepatitis C Virus with Leukocyte‐Related Amino Acids in the Setting of Liver Transplantation. The Journal of Infectious Diseases 2008; 198(11): 1656 doi: 10.1086/592986
|
| 4 |
Peng Peng Ip, Hans W. Nijman, Jan Wilschut, Toos Daemen. Therapeutic vaccination against chronic hepatitis C virus infection. Antiviral Research 2012; 96(1): 36 doi: 10.1016/j.antiviral.2012.07.006
|
| 5 |
Hisham O. Akbar. Can chronic hepatitis C resolve spontaneously? Case report and review. Arab Journal of Gastroenterology 2011; 12(1): 51 doi: 10.1016/j.ajg.2011.01.010
|
| 6 |
Zania Stamataki, Joe Grove, Peter Balfe, Jane A. McKeating. Hepatitis C Virus Entry and Neutralization. Clinics in Liver Disease 2008; 12(3): 693 doi: 10.1016/j.cld.2008.03.008
|
| 7 |
Marc G. Ghany, Christopher M. Walker, Patrizia Farci. The Liver. 2020; : 868 doi: 10.1002/9781119436812.ch65
|
| 8 |
George Koutsoudakis, Jakub Dragun, Sofia Pérez-del-Pulgar, Mairene Coto-Llerena, Laura Mensa, Gonzalo Crespo, Patricia González, Miquel Navasa, Xavier Forns, Erica Villa. Interplay between Basic Residues of Hepatitis C Virus Glycoprotein E2 with Viral Receptors, Neutralizing Antibodies and Lipoproteins. PLoS ONE 2012; 7(12): e52651 doi: 10.1371/journal.pone.0052651
|
| 9 |
Kathie-Anne Walters, Michael G. Katze. Using high-throughput genomics to study hepatitis C: What determines the outcome of infection?. Antiviral Research 2009; 81(3): 198 doi: 10.1016/j.antiviral.2008.12.005
|
| 10 |
Denis Leclerc. Plant Viral Vectors. Current Topics in Microbiology and Immunology 2011; 375: 47 doi: 10.1007/82_2011_183
|
| 11 |
Laura Esteban-Riesco, Frantz Depaulis, Alain Moreau, Yannick Bacq, Frédéric Dubois, Alain Goudeau, Catherine Gaudy-Graffin. Rapid and sustained autologous neutralizing response leading to early spontaneous recovery after HCV infection. Virology 2013; 444(1-2): 90 doi: 10.1016/j.virol.2013.05.037
|
| 12 |
Ziqing Liu, Xiugen Zhang, Qigui Yu, Johnny J. He. Exosome-associated hepatitis C virus in cell cultures and patient plasma. Biochemical and Biophysical Research Communications 2014; 455(3-4): 218 doi: 10.1016/j.bbrc.2014.10.146
|
| 13 |
Erika A. Eksioglu, Jennifer Bess, Graham Jones, Jennifer Dettloff, Parinda Dangmeon, Hui-Jia Dong, Haizhen Zhu, Roberto Firpi, Yiling Xu, David R. Nelson, Chen Liu. Characterization of Anti-HCV Antibodies in IL-10-Treated Patients. Viral Immunology 2010; 23(4): 359 doi: 10.1089/vim.2009.0095
|
| 14 |
Giovanna Russelli, Paola Pizzillo, Gioacchin Iannolo, Floriana Barbera, Fabio Tuzzolino, Rosa Liotta, Mario Traina, Giovanni Vizzini, Bruno Gridelli, Ester Badami, Pier Giulio Conaldi, Birke Bartosch. HCV replication in gastrointestinal mucosa: Potential extra-hepatic viral reservoir and possible role in HCV infection recurrence after liver transplantation. PLOS ONE 2017; 12(7): e0181683 doi: 10.1371/journal.pone.0181683
|
| 15 |
Ester Badami, Rosalia Busà, Bruno Douradinha, Giovanna Russelli, Vitale Miceli, Alessia Gallo, Giovanni Zito, Pier Giulio Conaldi, Gioacchin Iannolo. Hepatocellular carcinoma, hepatitis C virus infection and miRNA involvement: Perspectives for new therapeutic approaches. World Journal of Gastroenterology 2022; 28(22): 2417-2428 doi: 10.3748/wjg.v28.i22.2417
|
| 16 |
Ziqing Liu, Johnny J. He. Cell-Cell Contact-Mediated Hepatitis C Virus (HCV) Transfer, Productive Infection, and Replication and Their Requirement for HCV Receptors. Journal of Virology 2013; 87(15): 8545 doi: 10.1128/JVI.01062-13
|
| 17 |
Kerstin Uhde-Holzem, Verena Schlösser, Sergei Viazov, Rainer Fischer, Ulrich Commandeur. Immunogenic properties of chimeric potato virus X particles displaying the hepatitis C virus hypervariable region I peptide R9. Journal of Virological Methods 2010; 166(1-2): 12 doi: 10.1016/j.jviromet.2010.01.017
|
| 18 |
Mirjam B. Zeisel, François‐Loïc Cosset, Thomas F. Baumert. Host neutralizing responses and pathogenesis of hepatitis C virus infection†. Hepatology 2008; 48(1): 299 doi: 10.1002/hep.22307
|
| 19 |
Tanja B. Jensen, Judith M. Gottwein, Troels K. H. Scheel, Anne M. Hoegh, Jesper Eugen‐Olsen, Jens Bukh. Highly Efficient JFH1‐Based Cell‐Culture System for Hepatitis C Virus Genotype 5a: Failure of Homologous Neutralizing‐Antibody Treatment to Control Infection. The Journal of Infectious Diseases 2008; 198(12): 1756 doi: 10.1086/593021
|
| 20 |
Ashraf A. Tabll, Rehab I. Moustafa, Yasmine S. El Abd, Noha G. Bader El Din, Reem El-Shenawy, Hassan Yousef, Manal Hussein, Reham M. Dawood, Moataza H. Omran, Mostafa K. El-Awady. MOUSE MONOCLONAL ANTIBODY TOWARDS E1 SPECIFIC EPITOPE BLOCKS VIRAL ENTRY AND INTRACELLULAR VIRAL REPLICATIONIN VITRO. Journal of Immunoassay and Immunochemistry 2014; 35(1): 60 doi: 10.1080/15321819.2013.792831
|
| 21 |
Françoise Stoll-Keller, Samira Fafi-Kremer, Philippe Wolf, Michel Doffoël, Thomas Baumert. Proposition d’une nouvelle stratégie pour éviter la réinfection du greffon par le virus de l’hépatite C après transplantation hépatique. Bulletin de l'Académie Nationale de Médecine 2008; 192(8): 1657 doi: 10.1016/S0001-4079(19)32669-X
|
| 22 |
Kyung Hee Kang, Yasuhiro Yamamura, Maria P. Carlos, Nicolas Karvelas, In-Sup Kim, Deepa Sunkara, Rebecca Rivera, Murray B. Gardner, David E. Anderson, Francisco Diaz-Mitoma, José V. Torres, Juan P. Marquez. Synthetic Antigens Representing the Antigenic Variation of Human Hepatitis C Virus. Viral Immunology 2010; 23(5): 497 doi: 10.1089/vim.2010.0043
|
| 23 |
Flavia Bernini, Erika Ebranati, Chiara De Maddalena, Renata Shkjezi, Laura Milazzo, Alessandra Lo Presti, Massimo Ciccozzi, Massimo Galli, Gianguglielmo Zehender, John Tavis. Within-Host Dynamics of the Hepatitis C Virus Quasispecies Population in HIV-1/HCV Coinfected Patients. PLoS ONE 2011; 6(1): e16551 doi: 10.1371/journal.pone.0016551
|
| 24 |
L. Alvarez‐Lajonchere, N. H. Shoukry, B. Grá, Y. Amador‐Cañizares, F. Helle, N. Bédard, I. Guerra, C. Drouin, J. Dubuisson, E. E. González‐Horta, G. Martínez, J. Marante, Z. Cinza, M. Castellanos, S. Dueñas‐Carrera. Immunogenicity of CIGB‐230, a therapeutic DNA vaccine preparation, in HCV‐chronically infected individuals in a Phase I clinical trial. Journal of Viral Hepatitis 2009; 16(3): 156 doi: 10.1111/j.1365-2893.2008.01058.x
|
| 25 |
|
| 26 |
Jie Cao, Zhihui Chen, Yanli Ren, Yuan Luo, Mingmei Cao, Wei Lu, Ping Zhao, Zhongtian Qi. Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice. Vaccine 2011; 29(20): 3714 doi: 10.1016/j.vaccine.2011.02.083
|
| 27 |
Mostafa K. El-Awady, Mohamed El Gendy, Imam Waked, Ashraf A. Tabll, Yasmin El Abd, Noha Bader El Din, Reem El Shenawy, Aleef Allam, Tawfeek H. Abdelhafez, Reham M. Dawood. WITHDRAWN: Immunogenicity and safety of HCV E1E2 peptide vaccine in chronically HCV-infected patients who did not respond to interferon based therapy. Vaccine 2013; doi: 10.1016/j.vaccine.2013.07.074
|
| 28 |
Helen J. Harris, Michelle J. Farquhar, Christopher J. Mee, Christopher Davis, Gary M. Reynolds, Adam Jennings, Ke Hu, Fei Yuan, HongKui Deng, Stefan G. Hubscher, Jang H. Han, Peter Balfe, Jane A. McKeating. CD81 and Claudin 1 Coreceptor Association: Role in Hepatitis C Virus Entry. Journal of Virology 2008; 82(10): 5007 doi: 10.1128/JVI.02286-07
|
| 29 |
L Alexa Thompson, Jayne Fenton, Carmen L Charlton. HCV reflex testing: A single-sample, low-contamination method that improves the diagnostic efficiency of HCV testing among patients in Alberta, Canada. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada 2022; 7(2): 97 doi: 10.3138/jammi-2021-0028
|
| 30 |
Xinjian Zhang, Jun Dou, Markus W. Germann. Characterization of the cellular immune response in hepatitis C virus infection. Medicinal Research Reviews 2009; 29(6): 843 doi: 10.1002/med.20157
|
| 31 |
Olga V. Masalova, Ekaterina I. Lesnova, Alexei V. Pichugin, Tatiana M. Melnikova, Vadim V. Grabovetsky, Natalia V. Petrakova, Olga A. Smirnova, Alexander V. Ivanov, Alexei D. Zaberezhny, Ravshan I. Ataullakhanov, Maria G. Isaguliants, Alla A. Kushch. The successful immune response against hepatitis C nonstructural protein 5A (NS5A) requires heterologous DNA/protein immunization. Vaccine 2010; 28(8): 1987 doi: 10.1016/j.vaccine.2009.10.097
|
| 32 |
Yuki Haga, Sydney Coates, Ranjit Ray. Hepatitis C virus chronicity and oncogenic potential: Vaccine development progress. Molecular Aspects of Medicine 2024; 99: 101305 doi: 10.1016/j.mam.2024.101305
|
| 33 |
Jean-Christophe Meunier, Jens Bukh, Giacomo Diaz, Pier-Angelo Tovo, Anna Maria Casadei, Isabella Quinti, Raffaele Iorio, Suzanne Emerson, Robert H. Purcell, Patrizia Farci. Neutralizing Antibodies to Hepatitis C Virus in Perinatally Infected Children Followed Up Prospectively. The Journal of Infectious Diseases 2011; 204(11): 1741 doi: 10.1093/infdis/jir631
|
| 34 |
Valentina Botti, Alessia Bianchi, Steven K. H. Foung, Marcello Merola, Robert J. Geraghty. The Hepatitis C Virus E1 Glycoprotein Undergoes Productive Folding but Accelerated Degradation When Expressed as an Individual Subunit in CHO Cells. PLoS ONE 2011; 6(8): e23838 doi: 10.1371/journal.pone.0023838
|
| 35 |
Joachim Lupberger, Mirjam B. Zeisel, Anita Haberstroh, Eva K. Schnober, Sophie Krieger, Eric Soulier, Christine Thumann, Cathy Royer, Samira Fafi-Kremer, Catherine Schuster, Françoise Stoll-Keller, Hubert E. Blum, Thomas F. Baumert. Virus-host interactions during hepatitis C virus entry — implications for pathogenesis and novel treatment approaches. Virologica Sinica 2008; 23(2): 124 doi: 10.1007/s12250-008-2943-x
|
| 36 |
Yalena Amador-Cañizares, Liz Alvarez-Lajonchere, Ivis Guerra, Ingrid Rodríguez-Alonso, Gillian Martínez-Donato, Julián Triana, Eddy E González-Horta, Angel Pérez, Santiago Dueñas-Carrera. Induction of IgA and sustained deficiency of cell proliferative response in chronic hepatitis C. World Journal of Gastroenterology 2008; 14(44): 6844-6852 doi: 10.3748/wjg.14.6844
|
| 37 |
Mirjam B. Zeisel, Isabel Fofana, Samira Fafi-Kremer, Thomas F. Baumert. Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies. Journal of Hepatology 2011; 54(3): 566 doi: 10.1016/j.jhep.2010.10.014
|